Phenelzine Sulfate (Novel Laboratories, Inc.)


Welcome to the PulseAid listing for the Phenelzine Sulfate drug offered from Novel Laboratories, Inc.. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novel Laboratories, Inc.
NON-PROPRIETARY NAME: Phenelzine Sulfate
SUBSTANCE NAME: PHENELZINE SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-02-14
END MARKETING DATE: 0000-00-00


Phenelzine Sulfate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPhenelzine Sulfate from Novel Laboratories, Inc.
LABELER NAME: Novel Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15(mg/1)
START MARKETING DATE: 2011-02-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 40032-360_c3334c58-bba0-44a7-8d65-51ac865dd21d
PRODUCT NDC: 40032-360
APPLICATION NUMBER: ANDA200181

Other PHENELZINE SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Golden State Medical Supply, Inc.Phenelzine Sulfate
Greenstone LLCphenelzine sulfate
Lupin Pharmaceuticals,Inc.Phenelzine Sulfate
Novel Laboratories, Inc.Phenelzine Sulfate
Parke-Davis Div of Pfizer IncNardil